Date	Severity	Status	Feedback
Oct 28 2014 5:23PM	Normal	Acknowledged	F15599 is also known as NLX-101. It is developed by Neurolixis Inc. as an orphan drug for Rett syndrome. See http://neurolixis.com/en/company/pipeline/nlx-101.html Adrian Newman-Tancredi PhD DSc, Chief Scientific Officer, Neurolixis Thanks for the comment. Do you have any reference that supports this name-structure association? If you can provide a link or reference, I will add the synonym to this record.
Feb 8 2013 3:36AM	Normal	Acknowledged	This compound is also known as F-15,599. Thanks for the comment. Do you have any reference that supports this name-structure association? If you can provide a link or reference, I will add the synonym to this record.